PhD in Infection and Antimicrobial Resistance in Leeds United Kingdom | University of Leeds

Contemporary healthcare depends on efficient antimicrobial approaches to combat infections, yet approximately seven decades since antibiotics gained widespread use, their long-term efficacy faces significant challenges. Antibiotics aren't a universal remedy – they must be administered carefully, as improper use can lead to complications like Clostridium difficile infections (an area where we maintain a recognized global research standing) and the development of resistance, potentially outweighing their advantages. Our extensive research team specializes in studying the spread, causes, detection, prevention, and management of infections acquired in healthcare settings. Anticipating the negative impacts of particular antibiotics, including their influence on microbial balance, can guide optimal prescription practices. We've created predictive models that replicate both the beneficial and harmful outcomes of antibiotic use. A crucial advancement in antibiotic utilization would involve accessible rapid testing methods capable of reliably confirming or excluding infections. As a core member of the National Institute for Health Research Leeds In Vitro Diagnostics Co-operative (NIHR Leeds MIC), we assist innovators in crafting and verifying new diagnostic tools.